Senti Biosciences Completes Merger With Dynamics Special Purpose Corp.

CFGI’s Capital Markets team assisted Senti Biosciences, Incorporated (“Senti Bio”) with the completion of its merger with Dynamics Special Purpose Corporation (“DYNS”) (Nasdaq: DYNS), a special purpose acquisition company.


Navigating the Proposed SEC Rules for Climate Disclosures

Background The SEC issued a long-anticipated proposed rule on March 21, 2022, surrounding the potential standardization of requirements for climate-related disclosures in registration statements and annual reports of public filers.


BCP Raptor Holdco LP Completes Reverse Merger With Altus Midstream Company

CFGI’s Capital Markets team assisted privately-owned BCP Raptor Holdco LP (“BCP”), the parent company of EagleClaw Midstream, with the completion of an all-stock business combination with Altus Midstream Company (Nasdaq: ALTM) (“Altus”), creating a unique, fully-integrated midstream company.


Capital Markets Advisory: 2021 Year in Review

2021 was an exciting year of growth for CFGI, which included a new partnership with CVC Capital Partners, one of the world’s largest private equity firms.


The Future Is Already Here, and CFOs Need to Transform Finance to Survive

Download the Whitepaper

Enjoy Technology Completes Business Combination With Marquee Raine Acquisition Corp.

CFGI’s Capital Markets team assisted Enjoy Technology, Inc.


Discover How to Streamline Financial Processes For an Efficient SPAC Merger

The SPAC merger process is a major undertaking for any organization with many moving parts, stakeholders and requirements.


Securities and Exchange Commission (SEC) Amends Requirements to MD&A

The Securities and Exchange Commission (SEC) recently adopted new amendments as part of an ongoing effort to “modernize and enhance” regulations related to financial disclosures as well as management’s discussion and analysis (MD&A).

More, Inc. Announces Closing of Initial Public Offering

CFGI’s Capital Markets team supported 1stdibs.